Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
CA 2814613 C · Owner: The Trustees Of The University Of Pennsylvania · Inventors: Vandenberghe, Luc H.; Alvira, Mauricio R.; Gao, Guangping
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Sequences of novel adeno-associated virus capsids and vectors and host cells containing these sequences are provided. Also described are methods of using such host cells and vectors in production of rAAV particles. AAV-mediated delivery of therapeutic and immunogenic genes using the vectors of the invention is also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 30, 2004 and granted October 18, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 30, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 30, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.